Cryopyrin-Associated Periodic Syndromes - 19 Studies Found Completed : The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada : Cryopyrin Associated Periodic Syndrome : 2010-03-25 : Drug: canakinumab (company code: ACZ885D) Terminated : HL2351 CAPS Phase II Study : Cryopyrin‑Associated Periodic Syndromes (CAPS) : 2016-05-10 : Drug: HL2351 The dose will be adjusted based on disease activities Recruiting : Kineret CAPS Post Authorisation Study : Cryopyrin-Associated Periodic Syndromes : 2014-12-01 : Drug: anakinra (Kineret) Other Name: Kineret Completed : Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease : Cryopyrin-associated Periodic Syndromes Familial Cold Autoinfla : 2011-02-22 : Drug: ACZ885 Completed : Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase : Cryopyrin-associated Periodic Syndromes Familial Cold Autoinfla : 2009-10-06 : Drug: canakinumab canakinumab Completed : Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease : Cryopyrin-Associated Periodic Syndromes Familial Cold Autoinfla : 2008-05-27 : Drug: Canakinumab (ACZ885) 6 mL glass vial containing 150 mg lyophilized Canakinumab reconstituted with Completed : Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) : Familial Cold Autoinflammatory Syndrome (FCAS) Familial Cold Urticaria Drug: rilonacept 160 mg Rilona Completed : Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients : Cryopyrin-associated Periodic Syndromes (CAPS) Familial Cold Au : 2010-09-30 Completed : Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS) : Muckle-Wells Syndrome Schnitzler Syndrome : 2010-01-07 : Drug: rilonacept 160mg of rilonacept 1x/week Other N Recruiting : Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases) : NOMID CAPS DIRA NLRC4-MA : 2016-11-23 Next >>>